HomeStock SectorsEnergy StocksOil Prices Near 2-Week...

Oil Prices Near 2-Week Highs on OPEC+ Output and US Tariffs

climbed Tuesday, hovering near two-week highs as markets absorbed the impact of a larger-than-expected OPEC+ production increase and ongoing uncertainty around US trade policy.

As of mid-afternoon, was up 89 cents at $70.47 per barrel, while US West Texas Intermediate rose 80 cents to $68.73. Both benchmarks are on track for their highest close since June 24.

OPEC+ on Saturday approved a 548,000 barrel-per-day (bpd) production hike for August, outpacing the 411,000 bpd monthly increases seen earlier this summer. The move accelerates the rollback of the group’s 2.2 million bpd in voluntary cuts and hints at a similar bump likely to be announced at the group’s next meeting on August 3.

Despite the higher output, tight middle distillate inventories and ongoing Red Sea shipping disruptions have helped keep prices supported. Analysts at Rystad Energy noted that actual physical supply remains tighter than headline production figures suggest.

US trade policy added further volatility. President Trump announced new tariffs on 14 countries, including 25 percent duties on imports from Japan and South Korea, and up to 40 percent for others. Both Japan and South Korea have said they will attempt to negotiate exemptions ahead of the August implementation. The move has raised fears of a global economic slowdown that could dampen oil demand.

Traders are also awaiting weekly US inventory data. The API and EIA are set to report Tuesday and Wednesday, respectively. Analysts expect a draw of 2.8 million barrels from crude stocks for the week ending July 4, which would be the sixth draw in seven weeks.

Looking ahead, analysts at HSBC and Commerzbank (ETR:) both see Brent slipping back to around $65 this fall, as seasonal demand fades and OPEC+ barrels hit the market.

Original Post

Most Popular

More from Author

Risk Assets Rebound as Trump Pushes Tariff Deadline to August 1

After a volatile past day session, this one was way calmer...

Markets Today: RBNZ Rate Hold, Copper Volatility, DAX Moves Toward Fresh Highs

Chinese stocks are set to hit their highest level in three...

Read Now

Risk Assets Rebound as Trump Pushes Tariff Deadline to August 1

After a volatile past day session, this one was way calmer as Trump announced yet another delay in tariff deadlines – From the approaching July 9th to August 1st, apparently the final warning. The session began with the leading to the upside, followed by general mean-reversion all...

Gilead’s Lenacapavir Plan Faces Global Hurdles As It Commits To No-Profit Access for 2 Million – Gilead Sciences (NASDAQ:GILD)

Gilead Sciences, Inc. GILD on Wednesday announced a strategic partnership agreement with the Global Fund to Fight AIDS, Tuberculosis and Malaria to supply lenacapavir — Gilead’s twice-yearly injectable HIV-1 capsid inhibitor — for the prevention of HIV as pre-exposure prophylaxis (PrEP).Through the agreement, Gilead will supply enough...

Markets Today: RBNZ Rate Hold, Copper Volatility, DAX Moves Toward Fresh Highs

Chinese stocks are set to hit their highest level in three years as investors hope for new steps to fight deflation and boost the economy. Meanwhile, dropped in London after President Donald Trump issued a new tariff warning.Asian Market WrapThe Shanghai Stock Exchange Composite Index rose...

FDA Approves New Dosing Schedule For Eli Lilly’s Kisunla In Alzheimer’s Treatment – Eli Lilly (NYSE:LLY)

The U.S. Food and Drug Administration (FDA) has approved a label update with a new recommended titration dosing schedule for Eli Lilly and Co.’s LLY Kisunla (donanemab-azbt) once-monthly amyloid-targeting therapy for adults with early symptomatic Alzheimer’s disease (AD). The FDA approved the drug in July 2024.In the TRAILBLAZER-ALZ 6...

H2 2025: Room for Optimism, Risk for Complacency

Reasons To Be Fearful, Reasons To Be Cheerful It was an eventful first half of the year, to say the least... In January, the rise of DeepSeek was a wake-up call for the world, demonstrating that China is a major competitor to the US in AI and technology. The...

Merck Strikes $10-Billion Deal For Verona, Secures First-In-Class COPD Drug – Merck & Co (NYSE:MRK), Verona Pharma (NASDAQ:VRNA)

Merck & Co. Inc. MRK agreed on Wednesday to acquire Verona Pharma plc VRNA for $107 per American Depository Share (ADS) for a total transaction value of approximately $10 billion. Each ADS represents eight ordinary shares of Verona Pharma.Through the acquisition of this respiratory disease-focused company, Merck...

The Energy Report: Demand Exceeding Supply

It’s the oldest story in the book. Prices go up when demand exceeds supply, not only in oil and products but in wholesale power, driving up electricity costs. The Energy Information Administration (EIA) in its Short-Term Energy Outlook confirmed that we have a global supply deficit. Not only...

Altcoin Rotation Gains Steam as Bitcoin and Ethereum Take a Backseat

Despite increasing trade tensions and tariff worries, crypto continues to hold up. More than that, the group is actually performing pretty well. is leaning on a potential breakout, but it’s not doing the heavy lifting right now. To some extent, neither is . Instead, it’s more broad. Stellar,...

DAX Pushes Higher as EU Edges Closer to Tariff Deal With US

rises as investors await trade news from Trump. shows resilience despite a rise in inventories and uncertainty over trade tariffs. The DAX, along with European indices, is inching higher on Wednesday, supported by defence stocks as investors wait for news on a trade deal with the...

Oil: Can the Market Absorb OPEC+ Output Hikes?

OPEC+ surprised markets by announcing a larger-than-expected August output hike of 548,000 bpd. Analysts say actual supply increases remain limited due to ongoing compensation cuts. Strong summer demand, especially from Asia, is expected to absorb the added barrels, but demand could falter this autumn. OPEC+ never fails to surprise speculators...

US Dollar Fights an Uphill Battle Amidst Mounting Tariff Pressure

More Trump letters to be sent, with copper, chips, and pharma next on the tariff list Dollar struggles to hold recent gains, except versus the yen US equities are on the back foot, underperforming their European counterparts RBNZ stands pat; Antipodeans post small gains against the greenback Dollar Is Swimming UpstreamThe...

Big Oil Faces Weaker Quarter, but OPEC+ Output Move Signals Underlying Strength

Shell and Exxon warned of weaker Q2 earnings due to lower oil and gas prices, with Exxon expecting a $1.5 billion hit. Despite bearish forecasts, OPEC+ raised output and prices rose, suggesting demand remains stronger than expected—challenging the EV-driven demand collapse narrative. Analysts view the dip as cyclical, not...